MSH|^~\&|PTH|RCH|||201911281123||ORU^R01|4116202|D|2.3|||AL|NE
PID|1||RC00006059|RC6052|LABTEST^ALASKA^ROLL||19900918|F||||||||||RC000066/17|9876521172
PV1|1|I
OBR|1|16191|00011964^18AS-24^PTH^18AS-24^16191||||20180824||||||LABTEST|201808241350|S^SURGICAL SPECIMEN^SURGICAL|||||18AS-24||201911281123|||SOUT
OBX|1|TX|Pathology Lab: Abbotsford Regional Hospital
OBX|2|TX|Phone: (604)851-4700x646545 Fax: (604)851-4858
OBX|3|TX| 
OBX|4|TX|Specimen Number: 18AS-24
OBX|5|TX| 
OBX|6|TX|DIAGNOSES
OBX|7|TX|TESTING BIZTALK 2013
OBX|8|TX| 
OBX|9|TX|SYNOPTIC REPORT
OBX|10|TX|--------  Esophagus tnm testing, 1  --------
OBX|11|TX| 
OBX|12|TX|SPECIMEN
OBX|13|TX|  Procedure:                           Esophagogastrectomy
OBX|14|TX| 
OBX|15|TX|TUMOUR
OBX|16|TX|  Tumour Site:                         Esophagus, not otherwise specified
OBX|17|TX|  Relationship of Tumour to
OBX|18|TX|  Esophagogastric Junction:            Not specified
OBX|19|TX|  Distance of Tumour Center from
OBX|20|TX|  Esophagogastric Junction:            Cannot be determined - TEST
OBX|21|TX|  Tumour Size:                         2.0 Centimeters (cm)
OBX|22|TX|  Histologic Type:                     Adenocarcinoma
OBX|23|TX|  Histologic Grade:                    G1:  Well differentiated
OBX|24|TX|  Tumour Extension:                    Tumour invades lamina propria
OBX|25|TX|  Lymphovascular Invasion:             Not identified
OBX|26|TX| 
OBX|27|TX|MARGINS
OBX|28|TX|                                       All margins are negative for invasive
OBX|29|TX|                                       carcinoma, dysplasia, and intestinal
OBX|30|TX|                                       metaplasia
OBX|31|TX|  Margins Examined:                    Proximal
OBX|32|TX|  Distance of Invasive Carcinoma from
OBX|33|TX|  Closest Margin:                      4.0 Centimeters (cm)
OBX|34|TX| 
OBX|35|TX|LYMPH NODES
OBX|36|TX|                                       No lymph nodes present
OBX|37|TX| 
OBX|38|TX|TREATMENT EFFECT
OBX|39|TX|                                       No known presurgical therapy
OBX|40|TX| 
OBX|41|TX|PATHOLOGIC STAGE
OBX|42|TX|                                       rypT1a(2) pNX pM1
OBX|43|TX|  pM Site(s):                          TEST
OBX|44|TX| 
OBX|45|TX|ANCILLARY STUDIES
OBX|46|TX|  Best Tumour Block:                   TEST
OBX|47|TX| 
OBX|48|TX|ADDITIONAL PATHOLOGIC FINDINGS
OBX|49|TX|                                       None identified
OBX|50|TX| 
OBX|51|TX|COMMENTS
OBX|52|TX|                                       TEST
OBX|53|TX| 
OBX|54|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017
OBX|55|TX|---------- End of Synoptic Report ----------
OBX|56|TX|--------  Mismatch Repair (MMR) Testing, 2  --------
OBX|57|TX| 
OBX|58|TX|SPECIMEN
OBX|59|TX|                                       Submitting Hospital Case Number: 18SS-99999;
OBX|60|TX|                                       Block Tested: XX
OBX|61|TX|  Pertains To:                         TESTING TESTING
OBX|62|TX| 
OBX|63|TX|RESULTS
OBX|64|TX|  IHC Interpretation
OBX|65|TX|                                       MMR abnormal - likely MLH1 gene defect:
OBX|66|TX|                                       Immunohistochemical stains for mismatch
OBX|67|TX|                                       repair proteins show defective MLH1 and PMS2
OBX|68|TX|                                       protein expression. Depending on the tumour
OBX|69|TX|                                       site, further testing (i.e. MLH1 promoter
OBX|70|TX|                                       methylation testing, etc.) may be needed to
OBX|71|TX|                                       differentiate between sporadic versus
OBX|72|TX|                                       germline MLH1 abnormality.
OBX|73|TX|  Comment(s):                          TESTING VERSION 7.0.1.5
OBX|74|TX| 
OBX|75|TX|---------- End of Synoptic Report ----------
OBX|76|TX|--------  Breast Biomarkers, 3  --------
OBX|77|TX| 
OBX|78|TX|SPECIMEN
OBX|79|TX|                                       Submitting Hospital Case Number: 18SS-99999;
OBX|80|TX|                                       Block Tested: 1A
OBX|81|TX| 
OBX|82|TX|BREAST BIOMARKER TESTS
OBX|83|TX|  ER:                                  Negative (Intensity: Negative, 0%), Allred
OBX|84|TX|                                       Score: 0/8
OBX|85|TX|  PR:                                  Negative (Intensity: Negative, 0%), Allred
OBX|86|TX|                                       Score: 0/8
OBX|87|TX|  HER2 by ISH:                         Negative (not amplified)
OBX|88|TX|    HER2 / CEP17 Ratio:                1.0
OBX|89|TX|    Average Number of HER2 Signals per
OBX|90|TX|    Cell:                              20
OBX|91|TX|    Average Number of CEP17 Signals
OBX|92|TX|    per Cell:                          20
OBX|93|TX|    Number of Invasive Tumour Cells
OBX|94|TX|    Counted:                           100
OBX|95|TX| 
OBX|96|TX|CONTROLS
OBX|97|TX|  ER Internal Positive Control:        Present
OBX|98|TX|  PR Internal Positive Control:        Present
OBX|99|TX| 
OBX|100|TX|METHODS
OBX|101|TX|  Cold Ischemia and Fixation Times
OBX|102|TX|  Meet the Requirements Specified in
OBX|103|TX|  the Latest Version of the ASCO / CAP
OBX|104|TX|  Guidelines:                          Yes
OBX|105|TX| 
OBX|106|TX|COMMENT(S)
OBX|107|TX|                                       TESTING V.1.0.0.64
OBX|108|TX| 
OBX|109|TX|---------- End of Synoptic Report ----------
OBX|110|TX|--------  Breast Biomarkers, 4  --------
OBX|111|TX| 
OBX|112|TX|SPECIMEN
OBX|113|TX|                                       Submitting Hospital Case Number: 18SS-99999;
OBX|114|TX|                                       Block Tested: 1A
OBX|115|TX|  Pertains To:                         TEST
OBX|116|TX| 
OBX|117|TX|BREAST BIOMARKER TESTS
OBX|118|TX|  ER:                                  Negative (Intensity: Negative, 0%), Allred
OBX|119|TX|                                       Score: 0/8
OBX|120|TX|  PR:                                  Negative (Intensity: Negative, 0%), Allred
OBX|121|TX|                                       Score: 0/8
OBX|122|TX|  HER2 by IHC:                         Negative (Score 0)
OBX|123|TX| 
OBX|124|TX|CONTROLS
OBX|125|TX|  ER Internal Positive Control:        Present
OBX|126|TX|  PR Internal Positive Control:        Present
OBX|127|TX| 
OBX|128|TX|METHODS
OBX|129|TX|  Cold Ischemia and Fixation Times
OBX|130|TX|  Meet the Requirements Specified in
OBX|131|TX|  the Latest Version of the ASCO / CAP
OBX|132|TX|  Guidelines:                          Yes
OBX|133|TX| 
OBX|134|TX|COMMENT(S)
OBX|135|TX|                                       TESTING V.1.0.0.65
OBX|136|TX| 
OBX|137|TX|---------- End of Synoptic Report ----------
OBX|138|TX|--------  Breast Invasive Carcinoma, 5  --------
OBX|139|TX| 
OBX|140|TX|SPECIMEN COMMENT
OBX|141|TX|  Pertains To:                         TEST
OBX|142|TX| 
OBX|143|TX|SPECIMEN
OBX|144|TX|                                       Breast; Excision (less than total
OBX|145|TX|                                       mastectomy); Laterality not specified
OBX|146|TX| 
OBX|147|TX|TUMOUR
OBX|148|TX|  Invasive Carcinoma:                  No residual invasive carcinoma after
OBX|149|TX|                                       presurgical (neoadjuvant) therapy
OBX|150|TX|    Histologic Grade:                  No residual invasive carcinoma after
OBX|151|TX|                                       presurgical (neoadjuvant) therapy
OBX|152|TX|    Tumour Focality:                   No residual invasive carcinoma after
OBX|153|TX|                                       presurgical (neoadjuvant) therapy
OBX|154|TX|    Tumour Size:                       No residual invasive carcinoma after
OBX|155|TX|                                       presurgical (neoadjuvant) therapy
OBX|156|TX|    Lymphovascular Invasion:           Not identified
OBX|157|TX|  In Situ Component:                   Not identified
OBX|158|TX| 
OBX|159|TX|MARGINS
OBX|160|TX|  Invasive Carcinoma Margins:          Cannot be assessed
OBX|161|TX|  DCIS Margins:                        No DCIS present in specimen
OBX|162|TX| 
OBX|163|TX|LYMPH NODES, REGIONAL
OBX|164|TX|                                       No lymph nodes present
OBX|165|TX| 
OBX|166|TX|PATHOLOGIC STAGE
OBX|167|TX|                                       pT0 pNX
OBX|168|TX| 
OBX|169|TX|ANCILLARY STUDIES
OBX|170|TX|  Best Tumour Block:                   TEST
OBX|171|TX|  Block Tested:                        A1
OBX|172|TX|  Results
OBX|173|TX|    ER:                                Negative (Intensity: Negative, 0%), Allred
OBX|174|TX|                                       Score: 0/8
OBX|175|TX|    HER2 by IHC:                       Negative (Score 0)
OBX|176|TX|    Ki-67:                             High (10% or greater)
OBX|177|TX|    Controls
OBX|178|TX|      ER Internal Positive Control:    Present
OBX|179|TX|    Methods
OBX|180|TX|      Cold Ischemia and Fixation Times
OBX|181|TX|      Meet the Requirements Specified
OBX|182|TX|      in the Latest Version of the
OBX|183|TX|      ASCO / CAP Guidelines:           No
OBX|184|TX|    Comment(s)
OBX|185|TX|                                       TEST
OBX|186|TX| 
OBX|187|TX|COMMENT(S)
OBX|188|TX|                                       TESTING V.7.0.0.12
OBX|189|TX| 
OBX|190|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017
OBX|191|TX|---------- End of Synoptic Report ----------
OBX|192|TX|--------  Esophagus, 6  --------
OBX|193|TX| 
OBX|194|TX|SPECIMEN COMMENT
OBX|195|TX|  Pertains To:                         TESTING V.7.0.0.6
OBX|196|TX| 
OBX|197|TX|SPECIMEN
OBX|198|TX|  Procedure:                           Esophagogastrectomy
OBX|199|TX| 
OBX|200|TX|TUMOUR
OBX|201|TX|  Tumour Site:                         Mid esophagus, upper thoracic esophagus
OBX|202|TX|  Relationship of Tumour to            Tumour midpoint lies in the distal esophagus
OBX|203|TX|  Esophagogastric Junction:            AND tumour involves the esophagogastric
OBX|204|TX|                                       junction
OBX|205|TX|  Distance of Tumour Center from
OBX|206|TX|  Esophagogastric Junction:            2.0 Centimeters (cm)
OBX|207|TX|  Tumour Size:                         5.0 x 2.5 x 2.0 Centimeters (cm)
OBX|208|TX|  Histologic Type:                     Adenocarcinoma
OBX|209|TX|  Histologic Grade:                    G1:  Well differentiated
OBX|210|TX|  Tumour Extension:                    Tumour invades lamina propria
OBX|211|TX|  Lymphovascular Invasion:             Not identified
OBX|212|TX|  Perineural Invasion:                 Present
OBX|213|TX| 
OBX|214|TX|MARGINS
OBX|215|TX|                                       All margins are negative for invasive
OBX|216|TX|                                       carcinoma, dysplasia, and intestinal
OBX|217|TX|                                       metaplasia
OBX|218|TX|  Margins Examined:                    Proximal, Distal
OBX|219|TX|  Distance of Invasive Carcinoma from
OBX|220|TX|  Closest Margin:                      4.0 Centimeters (cm)
OBX|221|TX|  Closest Margin:                      Distal
OBX|222|TX| 
OBX|223|TX|LYMPH NODES
OBX|224|TX|                                       No lymph nodes present
OBX|225|TX| 
OBX|226|TX|TREATMENT EFFECT
OBX|227|TX|                                       No known presurgical therapy
OBX|228|TX| 
OBX|229|TX|PATHOLOGIC STAGE
OBX|230|TX|                                       pT1a pNX
OBX|231|TX| 
OBX|232|TX|ANCILLARY STUDIES
OBX|233|TX|  Best Tumour Block:                   TEST
OBX|234|TX| 
OBX|235|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017
OBX|236|TX|---------- End of Synoptic Report ----------
OBX|237|TX|--------  Bone Marrow - Aspiration; Core Biopsy, 7  --------
OBX|238|TX| 
OBX|239|TX|SPECIMEN
OBX|240|TX|  Specimen:                            Bone marrow aspiration and Bone marrow core
OBX|241|TX|                                       biopsy
OBX|242|TX|  Procedure:                           Aspiration and Biopsy
OBX|243|TX|    Aspiration Site:                   Right posterior iliac crest
OBX|244|TX|    Biopsy Site:                       Right posterior iliac crest
OBX|245|TX| 
OBX|246|TX|TUMOUR
OBX|247|TX|  Histologic Type based on 2017 WHO
OBX|248|TX|  classification:                      Acute promyelocytic leukemia with PML-RARA
OBX|249|TX|    Comments:                          test test test
OBX|250|TX| 
OBX|251|TX|ANCILLARY STUDIES
OBX|252|TX|  Immunophenotyping:                   Performed
OBX|253|TX|  Cytogenetic Studies:                 Performed
OBX|254|TX|  Fluorescence In Situ Hybridization:  Performed
OBX|255|TX|  Molecular Genetic Studies:           Performed
OBX|256|TX| 
OBX|257|TX|ADDITIONAL FINDINGS
OBX|258|TX|                                       test
OBX|259|TX| 
OBX|260|TX|COMMENTS
OBX|261|TX|                                       testing v.7.0.1.6
OBX|262|TX| 
OBX|263|TX|Based on CAP eCC January 2018
OBX|264|TX|---------- End of Synoptic Report ----------
OBX|265|TX|--------  Breast Biomarkers, 8  --------
OBX|266|TX| 
OBX|267|TX|SPECIMEN
OBX|268|TX|                                       Submitting Hospital Case Number: TESTING
OBX|269|TX|                                       V.1.0.0.66; Block Tested: 1A
OBX|270|TX|  Pertains To:                         TEST
OBX|271|TX| 
OBX|272|TX|BREAST BIOMARKER TESTS
OBX|273|TX|  ER:                                  Negative (Intensity: Intermediate, < 1%),
OBX|274|TX|                                       Allred Score: 3/8
OBX|275|TX|    Comment:                           The ASCO/CAP guidelines recommend that
OBX|276|TX|                                       carcinomas with <1% positive cells be
OBX|277|TX|                                       considered negative for ER and PgR. However,
OBX|278|TX|                                       carcinomas with <1% positive cells and
OBX|279|TX|                                       intensity scores of 2 or 3 are rare
OBX|280|TX|                                       carcinomas, and their response to hormonal
OBX|281|TX|                                       therapy has not been specifically studied.
OBX|282|TX|  PR:                                  Negative (Intensity: Weak, < 1%), Allred
OBX|283|TX|                                       Score: 2/8
OBX|284|TX|  HER2 by IHC:                         Negative (Score 1+)
OBX|285|TX| 
OBX|286|TX|CONTROLS
OBX|287|TX|  ER Internal Positive Control:        Present
OBX|288|TX|  PR Internal Positive Control:        Present
OBX|289|TX| 
OBX|290|TX|---------- End of Synoptic Report ----------
OBX|291|TX|--------  Ewing Sarcoma Resection, 9  --------
OBX|292|TX| 
OBX|293|TX|SPECIMEN COMMENT
OBX|294|TX|  Pertains To:                         testing v.2.0.0.39
OBX|295|TX| 
OBX|296|TX|CLINICAL
OBX|297|TX|  Preresection Treatment:              No known preresection therapy
OBX|298|TX| 
OBX|299|TX|SPECIMEN
OBX|300|TX|  Procedure:                           test
OBX|301|TX| 
OBX|302|TX|TUMOUR
OBX|303|TX|  Tumour Site:                         Osseous
OBX|304|TX|    Osseous:                           Pelvic bones, sacrum, coccyx and associated
OBX|305|TX|                                       joints - test
OBX|306|TX|  Tumour Size:                         6 cm
OBX|307|TX|  Primary Tumour Location:             Tumour extension into soft tissue
OBX|308|TX|  Lymph-Vascular Invasion:             Present
OBX|309|TX| 
OBX|310|TX|MARGINS
OBX|311|TX|                                       Margins negative for tumour
OBX|312|TX|  Distance of Tumour From Closest Bone
OBX|313|TX|  Margin:                              4 cm
OBX|314|TX|  Distance of Tumour From Closest Soft
OBX|315|TX|  Tissue Margin:                       3 cm
OBX|316|TX|  Distance of Tumour From Closest
OBX|317|TX|  Other (e.g. parenchymal) Margin:     2 cm
OBX|318|TX|  Comment:                             test
OBX|319|TX| 
OBX|320|TX|LYMPH NODES, REGIONAL
OBX|321|TX|                                       No lymph nodes present
OBX|322|TX| 
OBX|323|TX|PATHOLOGIC STAGE
OBX|324|TX|  Distant Metastasis (pM):             Present
OBX|325|TX|    Site(s):                           test
OBX|326|TX| 
OBX|327|TX|ADDITIONAL PATHOLOGIC FINDINGS
OBX|328|TX|                                       test
OBX|329|TX| 
OBX|330|TX|ANCILLARY STUDIES
OBX|331|TX|  Best Tumour Block:                   test
OBX|332|TX|  Immunohistochemistry:                test
OBX|333|TX|  Cytogenetic Findings:                No rearrangement identified
OBX|334|TX| 
OBX|335|TX|COMMENT(S)
OBX|336|TX|                                       test
OBX|337|TX| 
OBX|338|TX|Based on CAP eCC February 2019
OBX|339|TX|---------- End of Synoptic Report ----------
OBX|340|TX|                                                    ____________________________________
OBX|341|TX|                                                    Teresa Chow
OBX|342|TX|                                                    Electronically signed: 28/Nov/2019
OBX|343|TX| 
OBX|344|TX|--------------------------------------------------------------------------------------------
OBX|345|TX| 
OBX|346|TX| 
OBX|347|TX| 
OBX|348|TX| 
OBX|349|TX| 
OBX|350|TX| 
OBX|351|TX| 
OBX|352|TX| 
OBX|353|TX| 
OBX|354|TX| 
OBX|355|TX| 
OBX|356|TX| 
OBX|357|TX| 
OBX|358|TX| 
OBX|359|TX| 

MSH|^~\&|PTH|SMH|||201911281124||ORU^R01|4116203|D|2.3|||AL|NE
PID|1||SM00040261|SM40228|LABTEST^ABDOH^||20160920|F||||||||||SM003631/18|9876478783
PV1|1|O
OBR|1|23902|00018150^19AS-8^PTH^19AS-8^23902||||20190304|||||||201903041456|S^SURGICAL SPECIMEN^SURGICAL|||||19AS-8||201911281124|||SOUT
OBX|1|TX|Pathology Lab: Abbotsford Regional Hospital
OBX|2|TX|Phone: (604)851-4700x646545 Fax: (604)851-4858
OBX|3|TX| 
OBX|4|TX|Specimen Number: 19AS-8
OBX|5|TX| 
OBX|6|TX|REVISED REPORT
OBX|7|TX|THIS IS A REVISED REPORT WHICH CORRECTS THE ORIGINAL REPORT IN THE **HIGHLIGHTED** AREAS.
OBX|8|TX| 
OBX|9|TX|DIAGNOSES
OBX|10|TX|TESTING BIZTALK 2013
OBX|11|TX| 
OBX|12|TX|SYNOPTIC REPORT
OBX|13|TX|--------  Endometrium - Hysterectomy, 1  --------
OBX|14|TX| 
OBX|15|TX|SPECIMEN
OBX|16|TX|  Procedure:                           Radical hysterectomy
OBX|17|TX| 
OBX|18|TX|TUMOUR
OBX|19|TX|  Histologic Type:                     Endometrioid carcinoma with secretory
OBX|20|TX|                                       differentiation
OBX|21|TX|  Histologic Grade:                    FIGO grade 2
OBX|22|TX|  Tumour Size:                         3 Centimeters (cm)
OBX|23|TX|  Myometrial Invasion:                 Present
OBX|24|TX|    Depth of Invasion:                 2 Millimeters (mm)
OBX|25|TX|    Myometrial Thickness:              2 Millimeters (mm)
OBX|26|TX|    Percentage of Myometrial Invasion: 100%
OBX|27|TX|  Cervical Stromal Invasion:           Present
OBX|28|TX|  Other Tissue Involvement / Organ
OBX|29|TX|  Involvement:                         Not applicable
OBX|30|TX|  Lymph Vascular Invasion:             Focal (2 or fewer)
OBX|31|TX| 
OBX|32|TX|MARGINS
OBX|33|TX|  Parametrial / Paracervical Margin:   Positive for carcinoma
OBX|34|TX| 
OBX|35|TX|LYMPH NODES, REGIONAL
OBX|36|TX|  Number of Sentinel Node(s) Examined: 2
OBX|37|TX|  Site of Sentinel Node(s) Examined:   Pelvic
OBX|38|TX|  Laterality of Sentinel Node(s)
OBX|39|TX|  Examined:                            Right
OBX|40|TX|  Number of Sentinel Nodes with
OBX|41|TX|  Macrometastasis:                     1
OBX|42|TX|  Number of Sentinel Nodes with
OBX|43|TX|  Micrometastasis:                     0
OBX|44|TX|  Number of Sentinel Nodes with
OBX|45|TX|  Isolated Tumour Cells:               0
OBX|46|TX|  Site of Sentinel Node(s) with
OBX|47|TX|  Tumour:                              Pelvic
OBX|48|TX|  Laterality of Sentinel Node(s) with
OBX|49|TX|  Tumour:                              Right
OBX|50|TX|  Pelvic Lymph Nodes (non-sentinel):   No pelvic nodes present
OBX|51|TX|  Para-Aortic Lymph Nodes
OBX|52|TX|  (non-sentinel):                      No para-aortic nodes present
OBX|53|TX| 
OBX|54|TX|PATHOLOGIC STAGE
OBX|55|TX|                                       pT2 pN1a
OBX|56|TX| 
OBX|57|TX|ANCILLARY STUDIES
OBX|58|TX|  Best Tumour Block:                   test
OBX|59|TX|  Biomarker Testing:                   Performed, to follow: test
OBX|60|TX| 
OBX|61|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017
OBX|62|TX|---------- End of Synoptic Report ----------
OBX|63|TX|--------  Kidney - Nephrectomy, Partial or Radical, 2  --------
OBX|64|TX| 
OBX|65|TX|SPECIMEN COMMENT
OBX|66|TX|  Pertains To:                         V.7.0.0.6
OBX|67|TX| 
OBX|68|TX|SPECIMEN
OBX|69|TX|  Procedure:                           Radical nephrectomy
OBX|70|TX|  Specimen Laterality:                 Right
OBX|71|TX| 
OBX|72|TX|TUMOUR
OBX|73|TX|  Tumour Focality:                     Unifocal
OBX|74|TX|  Tumour Size:                         3 Centimeters (cm)
OBX|75|TX|  Histologic Type:                     Clear cell renal cell carcinoma
OBX|76|TX|  Histologic Grade (WHO / ISUP Grade): G3
OBX|77|TX|  Tumour Extension:                    Tumour extension into inferior vena cava
OBX|78|TX|  Tumour Necrosis:                     Not identified
OBX|79|TX|  Lymphovascular Invasion:             Not identified
OBX|80|TX|  Sarcomatoid Features:                Not identified
OBX|81|TX|  Rhabdoid Features:                   Not identified
OBX|82|TX| 
OBX|83|TX|MARGINS
OBX|84|TX|                                       Positive for invasive carcinoma
OBX|85|TX|  Margin(s):                           Renal sinus soft tissue margin
OBX|86|TX| 
OBX|87|TX|LYMPH NODES, REGIONAL
OBX|88|TX|                                       No lymph nodes present
OBX|89|TX| 
OBX|90|TX|PATHOLOGIC STAGE
OBX|91|TX|                                       pT3 pNX
OBX|92|TX| 
OBX|93|TX|ANCILLARY STUDIES
OBX|94|TX|  Best Tumour Block:                   TEST
OBX|95|TX| 
OBX|96|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017
OBX|97|TX|---------- End of Synoptic Report ----------
OBX|98|TX|--------  Major Salivary Gland, 3  --------
OBX|99|TX| 
OBX|100|TX|SPECIMEN COMMENT
OBX|101|TX|  Pertains to:                         Testing v.7.0.0.6
OBX|102|TX| 
OBX|103|TX|SPECIMEN
OBX|104|TX|  Procedure:                           Parotidectomy, not specified
OBX|105|TX| 
OBX|106|TX|TUMOUR
OBX|107|TX|  Tumour Site:                         Sublingual gland
OBX|108|TX|  Tumour Laterality:                   Bilateral
OBX|109|TX|  Tumour Focality:                     Unifocal
OBX|110|TX|  Histologic Type:                     Mucoepidermoid carcinoma, high grade
OBX|111|TX|  Tumour Size:                         3 Centimeters (cm)
OBX|112|TX|  Macroscopic Tumour Extension:        test
OBX|113|TX|  Lymphovascular Invasion:             Present
OBX|114|TX|  Perineural Invasion:                 Present
OBX|115|TX| 
OBX|116|TX|MARGINS
OBX|117|TX|                                       Negative for carcinoma
OBX|118|TX|  Distance of Tumour from Closest
OBX|119|TX|  Margin:                              3 Millimeters (mm)
OBX|120|TX|  Margin:                              test
OBX|121|TX| 
OBX|122|TX|LYMPH NODES, REGIONAL
OBX|123|TX|  Number of Lymph Nodes Examined:      4
OBX|124|TX|  Number of Lymph Nodes Involved:      Cannot be determined - test
OBX|125|TX|  Laterality of Lymph Nodes Involved:  Cannot be determined - test
OBX|126|TX|  Size of Largest Metastatic Deposit:  3 Centimeters (cm)
OBX|127|TX|  Extranodal Extension (ENE):          Not identified
OBX|128|TX| 
OBX|129|TX|PATHOLOGIC STAGE
OBX|130|TX|                                       pT2 pNX
OBX|131|TX| 
OBX|132|TX|ANCILLARY STUDIES
OBX|133|TX|  Best Tumour Block:                   test
OBX|134|TX| 
OBX|135|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017
OBX|136|TX|---------- End of Synoptic Report ----------
OBX|137|TX|--------  Colon and Rectum - Resection, 4  --------
OBX|138|TX| 
OBX|139|TX|SPECIMEN COMMENT
OBX|140|TX|  Pertains To:                         testing 7.0.0.18
OBX|141|TX| 
OBX|142|TX|SPECIMEN
OBX|143|TX|  Procedure:                           Right hemicolectomy
OBX|144|TX|  Macroscopic Tumour Perforation:      Present
OBX|145|TX| 
OBX|146|TX|TUMOUR
OBX|147|TX|  Tumour Site:                         Cecum
OBX|148|TX|  Histologic Type:                     Adenocarcinoma
OBX|149|TX|  Histologic Grade:                    G1: Well differentiated (Low grade)
OBX|150|TX|  Tumour Size:                         3 Centimeters (cm)
OBX|151|TX|  Tumour Extension:                    Tumour invades submucosa
OBX|152|TX|  Lymphovascular Invasion:             Present
OBX|153|TX|  Perineural Invasion:                 Present
OBX|154|TX|  Comment:                             testing tumour comment
OBX|155|TX| 
OBX|156|TX|MARGINS
OBX|157|TX|  Proximal Margin:                     Negative for invasive carcinoma
OBX|158|TX|    Status of Non-Invasive Tumour at
OBX|159|TX|    Proximal Margin:                   Positive for intramucosal adenocarcinoma
OBX|160|TX|  Distal Margin:                       Negative for invasive carcinoma,
OBX|161|TX|                                       intramucosal adenocarcinoma, high-grade
OBX|162|TX|                                       dysplasia and adenoma
OBX|163|TX|  Radial or Mesenteric Margin:         Negative for invasive carcinoma
OBX|164|TX|  Comment:                             testing optional margin comment
OBX|165|TX| 
OBX|166|TX|LYMPH NODES, REGIONAL
OBX|167|TX|  Number of Lymph Nodes Examined:      8
OBX|168|TX|  Number of Lymph Nodes Involved:      4
OBX|169|TX|  Tumour Deposits:                     Present
OBX|170|TX|    Number of Deposits:                5
OBX|171|TX|  Comment:                             testing lymph node comment
OBX|172|TX| 
OBX|173|TX|TREATMENT EFFECT
OBX|174|TX|                                       No known presurgical therapy
OBX|175|TX| 
OBX|176|TX|PATHOLOGIC STAGE
OBX|177|TX|                                       pT1 pN2a pM1
OBX|178|TX| 
OBX|179|TX|ANCILLARY STUDIES
OBX|180|TX|  Best Tumour Block:                   test
OBX|181|TX|  Biomarker Testing:                   Performed, to follow: test
OBX|182|TX| 
OBX|183|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017
OBX|184|TX|---------- End of Synoptic Report ----------
OBX|185|TX| 
OBX|186|TX|PREVIOUSLY REPORTED AS:
OBX|187|TX|The corrected TEST "TEST" was previously reported on TEST as "TEST".
OBX|188|TX| 
OBX|189|TX|HERE ARE THE SPECIAL CHARACTERS
OBX|190|TX|squiggly
OBX|191|TX|carrot \S\
OBX|192|TX|backslash \E\
OBX|193|TX|and \T\
OBX|194|TX|pipe \F\
OBX|195|TX|                                                    ____________________________________
OBX|196|TX|                                                    Teresa Chow
OBX|197|TX|                                                    Electronically signed: 28/Nov/2019
OBX|198|TX| 
OBX|199|TX|--------------------------------------------------------------------------------------------
OBX|200|TX| 
OBX|201|TX| 
OBX|202|TX| 
OBX|203|TX| 
OBX|204|TX| 
OBX|205|TX| 
OBX|206|TX| 
OBX|207|TX| 
OBX|208|TX| 
OBX|209|TX| 

MSH|^~\&|PTH|SCSC|||201911281124||ORU^R01|4116205|D|2.3|||AL|NE
PID|1||SU00003595|SU3573|TEST^ANNA^AMB||19410908|F||||||||||SU001325/17|9037813291
PV1|1|P
OBR|1|22048|00016634^19RS-2^PTH^19RS-2^22048||||201902041000||||||GASTROSCOPY|201902051138|S^SURGICAL SPECIMEN^SURGICAL|||||19RS-2||201911281124|||SOUT
OBX|1|TX|Pathology Lab: Royal Columbian Hospital
OBX|2|TX|Phone: (604)520-4352 Fax: (604)520-4409
OBX|3|TX| 
OBX|4|TX|Specimen Number: 19RS-2
OBX|5|TX| 
OBX|6|TX|DIAGNOSES
OBX|7|TX|TESTING BIZTALK 2013
OBX|8|TX| 
OBX|9|TX|SYNOPTIC REPORT
OBX|10|TX|--------  Lung - Resection, 1  --------
OBX|11|TX| 
OBX|12|TX|SPECIMEN
OBX|13|TX|  Procedure:                           Segmentectomy
OBX|14|TX|  Specimen Laterality:                 Left
OBX|15|TX| 
OBX|16|TX|TUMOUR
OBX|17|TX|  Tumour Site:                         Middle lobe
OBX|18|TX|  Tumour Focality:                     Single tumour
OBX|19|TX|  Total Tumour Size Inclusive of
OBX|20|TX|  Invasive and Lepidic Components:     4 Centimeters (cm)
OBX|21|TX|  Invasive Tumour Size:                4 Centimeters (cm)
OBX|22|TX|  Histologic Type:                     Adenocarcinoma in situ (AIS), mucinous
OBX|23|TX|  Visceral Pleura Invasion:            Present
OBX|24|TX|  Direct Invasion of Adjacent
OBX|25|TX|  Structures:                          Adjacent structures present but not involved
OBX|26|TX|  Lymphovascular Invasion:             Present
OBX|27|TX| 
OBX|28|TX|MARGINS
OBX|29|TX|                                       All margins are negative for carcinoma
OBX|30|TX|  Margins Examined:                    Bronchial
OBX|31|TX| 
OBX|32|TX|LYMPH NODES, REGIONAL
OBX|33|TX|                                       No lymph nodes present
OBX|34|TX| 
OBX|35|TX|TREATMENT EFFECT
OBX|36|TX|                                       Known presurgical therapy
OBX|37|TX|  Response to Presurgical Therapy:     Less than 10% residual viable tumour
OBX|38|TX| 
OBX|39|TX|PATHOLOGIC STAGE
OBX|40|TX|                                       mpT1c pNX pM1b
OBX|41|TX| 
OBX|42|TX|ANCILLARY STUDIES
OBX|43|TX|  Best Tumour Block(s):                test
OBX|44|TX| 
OBX|45|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017
OBX|46|TX|---------- End of Synoptic Report ----------
OBX|47|TX|--------  Breast Invasive Carcinoma, 2  --------
OBX|48|TX| 
OBX|49|TX|SPECIMEN COMMENT
OBX|50|TX|  Pertains To:                         Testing Original Checklist
OBX|51|TX| 
OBX|52|TX|SPECIMEN
OBX|53|TX|                                       Breast; Excision (less than total
OBX|54|TX|                                       mastectomy); Right
OBX|55|TX| 
OBX|56|TX|TUMOUR
OBX|57|TX|  Invasive Carcinoma:                  Present
OBX|58|TX|    Histologic Type:                   Invasive carcinoma of no special type
OBX|59|TX|                                       (ductal, not otherwise specified)
OBX|60|TX|    Histologic Grade (Nottingham
OBX|61|TX|    Histologic Score)
OBX|62|TX|      Glandular (Acinar) / Tubular
OBX|63|TX|      Differentiation:                 Score 1
OBX|64|TX|      Nuclear Pleomorphism:            Score 1
OBX|65|TX|      Mitotic Rate:                    Score 1
OBX|66|TX|      Overall Nottingham Score:        Grade 1
OBX|67|TX|    Tumour Size:                       Size of largest invasive focus cannot be
OBX|68|TX|                                       determined
OBX|69|TX|    Tumour Focality:                   Single focus of invasive carcinoma
OBX|70|TX|    Lymphovascular Invasion:           Not identified
OBX|71|TX|  In Situ Component:                   Not identified
OBX|72|TX| 
OBX|73|TX|MARGINS
OBX|74|TX|  Invasive Carcinoma Margins:          Positive for invasive carcinoma
OBX|75|TX|    Positive Margin(s):                Anterior
OBX|76|TX|    Extent:                            Anterior: 2 mm
OBX|77|TX|  DCIS Margins:                        No DCIS present in specimen
OBX|78|TX| 
OBX|79|TX|LYMPH NODES, REGIONAL
OBX|80|TX|                                       No lymph nodes present
OBX|81|TX| 
OBX|82|TX|TREATMENT EFFECT
OBX|83|TX|                                       No known presurgical therapy
OBX|84|TX| 
OBX|85|TX|PATHOLOGIC STAGE
OBX|86|TX|                                       pTX pNX
OBX|87|TX| 
OBX|88|TX|ANCILLARY STUDIES
OBX|89|TX|  Best Tumour Block(s):                test
OBX|90|TX|  Biomarker Testing/Results:           Performed previously
OBX|91|TX| 
OBX|92|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019
OBX|93|TX|---------- End of Synoptic Report ----------
OBX|94|TX|--------  Breast Invasive Carcinoma Option 1, 3  --------
OBX|95|TX| 
OBX|96|TX|SPECIMEN COMMENT
OBX|97|TX|  Pertains To:                         Testing Option 1
OBX|98|TX| 
OBX|99|TX|SPECIMEN
OBX|100|TX|                                       Breast; Excision (less than total
OBX|101|TX|                                       mastectomy); Right
OBX|102|TX| 
OBX|103|TX|TUMOUR
OBX|104|TX|  Invasive Carcinoma:                  Present
OBX|105|TX|    Histologic Type:                   Invasive carcinoma of no special type
OBX|106|TX|                                       (ductal, not otherwise specified)
OBX|107|TX|    Histologic Grade (Nottingham
OBX|108|TX|    Histologic Score)
OBX|109|TX|      Glandular (Acinar) / Tubular
OBX|110|TX|      Differentiation:                 Score 1
OBX|111|TX|      Nuclear Pleomorphism:            Score 1
OBX|112|TX|      Mitotic Rate:                    Score 1
OBX|113|TX|      Overall Nottingham Score:        Grade 1
OBX|114|TX|    Tumour Size:                       Size of largest invasive focus cannot be
OBX|115|TX|                                       determined
OBX|116|TX|    Tumour Focality:                   Single focus of invasive carcinoma
OBX|117|TX|    Lymphovascular Invasion:           Not identified
OBX|118|TX|  In Situ Component:                   Not identified
OBX|119|TX| 
OBX|120|TX|MARGINS
OBX|121|TX|  Invasive Carcinoma Margins:          Positive for invasive carcinoma
OBX|122|TX|    Positive Margin(s):                Anterior
OBX|123|TX|    Extent:                            Anterior: 2 mm
OBX|124|TX|    Negative Margins
OBX|125|TX|      Distance from Posterior Margin:  4 Millimeters (mm)
OBX|126|TX|      Distance from Superior Margin:   5 Millimeters (mm)
OBX|127|TX|  DCIS Margins:                        No DCIS present in specimen
OBX|128|TX| 
OBX|129|TX|LYMPH NODES, REGIONAL
OBX|130|TX|                                       No lymph nodes present
OBX|131|TX| 
OBX|132|TX|TREATMENT EFFECT
OBX|133|TX|                                       No known presurgical therapy
OBX|134|TX| 
OBX|135|TX|PATHOLOGIC STAGE
OBX|136|TX|                                       pTX pNX
OBX|137|TX| 
OBX|138|TX|ANCILLARY STUDIES
OBX|139|TX|  Best Tumour Block(s):                test
OBX|140|TX|  Biomarker Testing/Results:           Performed, addendum to follow
OBX|141|TX| 
OBX|142|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019
OBX|143|TX|---------- End of Synoptic Report ----------
OBX|144|TX|--------  Breast Invasive Carcinoma Option 2, 4  --------
OBX|145|TX| 
OBX|146|TX|SPECIMEN COMMENT
OBX|147|TX|  Pertains To:                         Testing Option 2
OBX|148|TX| 
OBX|149|TX|SPECIMEN
OBX|150|TX|                                       Breast; Excision (less than total
OBX|151|TX|                                       mastectomy); Right
OBX|152|TX| 
OBX|153|TX|TUMOUR
OBX|154|TX|  Invasive Carcinoma:                  Present
OBX|155|TX|    Histologic Type:                   Invasive carcinoma of no special type
OBX|156|TX|                                       (ductal, not otherwise specified)
OBX|157|TX|    Histologic Grade (Nottingham
OBX|158|TX|    Histologic Score)
OBX|159|TX|      Glandular (Acinar) / Tubular
OBX|160|TX|      Differentiation:                 Score 1
OBX|161|TX|      Nuclear Pleomorphism:            Score 1
OBX|162|TX|      Mitotic Rate:                    Score 1
OBX|163|TX|      Overall Nottingham Score:        Grade 1
OBX|164|TX|    Tumour Size:                       Size of largest invasive focus cannot be
OBX|165|TX|                                       determined
OBX|166|TX|    Tumour Focality:                   Single focus of invasive carcinoma
OBX|167|TX|    Lymphovascular Invasion:           Not identified
OBX|168|TX|  In Situ Component:                   Not identified
OBX|169|TX| 
OBX|170|TX|MARGINS
OBX|171|TX|  Invasive Carcinoma Margins:          Positive for invasive carcinoma
OBX|172|TX|    Positive Margin(s):                Anterior
OBX|173|TX|      Extent:                          Anterior: 2 mm
OBX|174|TX|    Distance from Negative Margins
OBX|175|TX|      Posterior Margin:                4 Millimeters (mm)
OBX|176|TX|      Superior Margin:                 5 Millimeters (mm)
OBX|177|TX|  DCIS Margins:                        No DCIS present in specimen
OBX|178|TX| 
OBX|179|TX|LYMPH NODES, REGIONAL
OBX|180|TX|                                       No lymph nodes present
OBX|181|TX| 
OBX|182|TX|TREATMENT EFFECT
OBX|183|TX|                                       No known presurgical therapy
OBX|184|TX| 
OBX|185|TX|PATHOLOGIC STAGE
OBX|186|TX|                                       pTX pNX
OBX|187|TX| 
OBX|188|TX|ANCILLARY STUDIES
OBX|189|TX|  Best Tumour Block(s):                test
OBX|190|TX|  Biomarker Testing/Results:           Performed previously
OBX|191|TX| 
OBX|192|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019
OBX|193|TX|---------- End of Synoptic Report ----------
OBX|194|TX|                                                    ____________________________________
OBX|195|TX|                                                    Teresa Chow
OBX|196|TX|                                                    Electronically signed: 28/Nov/2019
OBX|197|TX| 
OBX|198|TX|--------------------------------------------------------------------------------------------
OBX|199|TX| 
OBX|200|TX| 
OBX|201|TX| 
OBX|202|TX| 
OBX|203|TX| 
OBX|204|TX| 
OBX|205|TX| 
OBX|206|TX| 
OBX|207|TX| 
OBX|208|TX| 
OBX|209|TX|